Rosario Distefano
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
105
Citations
794
Est. group size
~11
Recurring co-author estimate
Active years
53
Publishing since 1974
Rosario Distefano's research focuses on small non-coding RNAs, especially microRNAs and their variant forms called isomiRs, and how they are altered in cancers such as breast, lung, and blood cancers. Work in this group involves developing computational tools and databases to catalog RNA modifications and using these to find potential diagnostic markers, such as blood-based tests for lung cancer. The research combines bioinformatics analysis of large public cancer genome datasets with molecular studies of specific genes and RNA regulatory mechanisms.
Publication output has grown substantially over the last decade, rising from about 1 paper per year in 2017 to a peak of 35 in 2023, with continued high activity through 2024-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 2055: Isoform-aware miRNA network mapping in NSCLC via computational consensus targeting and functional clustering.
Cancer Research · 2026
- Poly(A)-specific RNase (PARN) generates and regulates miR-125a-5p 3’-isoforms, displaying an altered expression in breast cancer
Signal Transduction and Targeted Therapy · 2024
- tRFUniverse: A comprehensive resource for the interactive analyses of tRNA-derived ncRNAs in human cancer
iScience · 2024
- A plasma miRNA-based classifier for small cell lung cancer diagnosis
Frontiers in Oncology · 2023
- Data from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Supplementary Figure Legends from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Supplementary Table 1 from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Supplementary Table 1 from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Supplementary Table 2 from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Supplementary Figure Legends from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Supplementary Figures from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Supplementary Table 2 from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Data from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Supplementary Figures from WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
2023
- Disparities in Lung Cancer: miRNA Isoform Characterization in Lung Adenocarcinoma
Cancers · 2022
- Cancer Research×8
- Signal Transduction and Targeted Therapy×4
- Methods in molecular biology×3
- Cancers×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Paolo Fadda
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Pierluigi Gasparini
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Giovanni Nigita
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Gian Luca Rampioni Vinciguerra
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Gianpiero Di Leva
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile